VNRX logo

VolitionRx Limited (VNRX) Selling, General & Administrative Expenses

Annual SGA

$16.92 M
+$514.70 K+3.14%

December 31, 2023

Summary

Performance

1-Year Change

+3.14%

3-Year Change

+158.72%

5-Year Change

+143.32%

15-Year Change

+154.21%

VNRX SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

36.39%
VNRX annual SGA is higher than 36.39% of companies in Healthcare sector

High & Low

All-time High

$16.92 M
VNRX annual SGA is currently at an all-time high

3-Year Low

$14.83 M
VNRX annual SGA is currently +14.12% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
VNRX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 26, 2025
VNRX next annual earnings announcement is scheduled for Mar 26, 2025

OtherVNRXexpensesmetrics:

Annual Total Expenses

$36.55 M
VNRX annual total expenses is $36.55 million

Annual Operating Expenses

$36.55 M
VNRX annual total operating expenses is $36.55 million

Annual Cost Of Goods Sold

-
VNRX annual cost of goods sold value is unknown

Annual Interest Expense

$221.60 K
VNRX annual interest expense is $221.60 thousand

Quarterly SGA

$2.82 M
-$803.00 K-22.18%

September 30, 2024

Summary

Performance

3-Month Change

-22.18%

1-Year Change

-35.53%

3-Year Change

-26.54%

5-Year Change

+121.46%

VNRX Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

24%
VNRX quarterly SGA is higher than 24% of companies in Healthcare sector

High & Low

All-time High

$5.36 M
VNRX quarterly SGA is currently -47.47% below its historical high of $5.36 million

3-Year Low

$2.82 M
VNRX quarterly SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
VNRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 26, 2025
VNRX next earnings announcement is scheduled for Mar 26, 2025

OtherVNRXexpensesmetrics:

Quarterly Total Expenses

$6.26 M
VNRX quarterly total expenses is $6.26 million

Quarterly Operating Expenses

$6.26 M
VNRX quarterly total operating expenses is $6.26 million

Quarterly Cost Of Goods Sold

-
VNRX quarterly cost of goods sold value is unknown

Quarterly Interest Expense

$89.50 K
VNRX quarterly interest expense is $89.50 thousand

TTM SGA

-$855.20 M
-$29.87 M-3.62%

September 30, 2024

Summary

Performance

3-Month Change

-5461.39%

1-Year Change

-5154.53%

3-Year Change

-8198.8%

5-Year Change

-15234.96%

VNRX TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

48.81%
VNRX TTM SGA is higher than 48.81% of companies in Healthcare sector

High & Low

All-time High

-$95.20 K

3-Year Low

-$855.20 M
VNRX TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
VNRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 26, 2025
VNRX next earnings announcement is scheduled for Mar 26, 2025

OtherVNRXexpensesmetrics:

Annual Total Expenses

$36.55 M
VNRX annual total expenses is $36.55 million

Annual Operating Expenses

$36.55 M
VNRX annual total operating expenses is $36.55 million

TTM Cost Of Goods Sold

-
VNRX TTM cost of goods sold value is unknown

TTM Interest Expense

$305.90 K
VNRX TTM interest expense is $305.90 thousand

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$16.92 M
VNRX annual SGA is $16.92 million

Annual Operating Expenses

$36.55 M
VNRX annual total operating expenses is $36.55 million

Annual Cost Of Goods Sold

-
VNRX annual cost of goods sold value is unknown

VNRX Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+3.1%-35.5%-5154.5%
3 y3 years+158.7%-26.5%-8198.8%
5 y5 years+143.3%+121.5%-10000.0%

VNRX Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+14.1%-47.5%at low-69.7%at low
5 y5-yearat high+208.5%-47.5%+257.3%-154.4%at low
alltimeall timeat high>+9999.0%-47.5%>+9999.0%<-9999.0%at low

VolitionRx Limited Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$2.82 M(-22.2%)
$14.67 M(-8.0%)
Jun 2024
-
$3.62 M(-6.4%)
$15.95 M(-3.7%)
Mar 2024
-
$3.87 M(-11.5%)
$16.57 M(-2.1%)
Dec 2023
$16.92 M(+3.1%)
$4.37 M(+6.7%)
$16.92 M(+2.1%)
Sep 2023
-
$4.09 M(-3.5%)
$16.57 M(+1.1%)
Jun 2023
-
$4.24 M(+0.5%)
$16.40 M(-3.0%)
Mar 2023
-
$4.22 M(+4.9%)
$16.90 M(+1.0%)
Dec 2022
$16.40 M(+10.6%)
$4.02 M(+2.7%)
$16.74 M(-7.4%)
Sep 2022
-
$3.92 M(-17.4%)
$18.08 M(+0.5%)
Jun 2022
-
$4.74 M(+16.8%)
$18.00 M(+11.8%)
Mar 2022
-
$4.06 M(-24.3%)
$16.10 M(+13.0%)
Dec 2021
$14.83 M(+126.7%)
$5.36 M(+39.9%)
$14.25 M(+34.9%)
Sep 2021
-
$3.83 M(+35.0%)
$10.56 M(+32.0%)
Jun 2021
-
$2.84 M(+28.8%)
$8.00 M(+17.2%)
Mar 2021
-
$2.21 M(+31.5%)
$6.83 M(+4.4%)
Dec 2020
$6.54 M(+19.2%)
$1.68 M(+31.9%)
$6.54 M(+15.7%)
Sep 2020
-
$1.27 M(-23.8%)
$5.65 M(-4.4%)
Jun 2020
-
$1.67 M(-13.1%)
$5.91 M(+0.1%)
Mar 2020
-
$1.92 M(+143.6%)
$5.90 M(+7.6%)
Dec 2019
$5.49 M(-21.1%)
$788.50 K(-48.4%)
$5.49 M(-6.8%)
Sep 2019
-
$1.53 M(-8.0%)
$5.88 M(-2.8%)
Jun 2019
-
$1.66 M(+10.5%)
$6.05 M(-3.3%)
Mar 2019
-
$1.50 M(+26.9%)
$6.26 M(-10.0%)
Dec 2018
$6.95 M(+4.5%)
$1.19 M(-30.3%)
$6.95 M(-5.9%)
Sep 2018
-
$1.70 M(-9.0%)
$7.39 M(-0.5%)
Jun 2018
-
$1.87 M(-14.9%)
$7.43 M(+3.3%)
Mar 2018
-
$2.20 M(+35.2%)
$7.19 M(+7.9%)
Dec 2017
$6.66 M(+47.1%)
$1.62 M(-6.4%)
$6.67 M(+14.9%)
Sep 2017
-
$1.74 M(+6.2%)
$5.80 M(+4.0%)
Jun 2017
-
$1.63 M(-2.1%)
$5.57 M(+7.9%)
Mar 2017
-
$1.67 M(+120.1%)
$5.17 M(+14.1%)
Dec 2016
$4.53 M(+15.9%)
$758.70 K(-49.8%)
$4.53 M(-5.0%)
Sep 2016
-
$1.51 M(+23.2%)
$4.77 M(+9.3%)
Jun 2016
-
$1.23 M(+19.1%)
$4.36 M(+14.9%)
Mar 2016
-
$1.03 M(+3.1%)
$3.79 M(-2.8%)
Dec 2015
$3.90 M(+104.6%)
$999.20 K(-9.6%)
$3.90 M(+12.2%)
Sep 2015
-
$1.11 M(+67.3%)
$3.48 M(+12.9%)
Jun 2015
-
$660.60 K(-42.0%)
$3.08 M(+15.0%)
Mar 2015
-
$1.14 M(+98.1%)
$2.68 M(+40.4%)
Dec 2014
$1.91 M
$575.10 K(-18.6%)
$1.91 M(-1.3%)
DateAnnualQuarterlyTTM
Sep 2014
-
$706.20 K(+172.6%)
$1.93 M(+18.8%)
Jun 2014
-
$259.10 K(-29.5%)
$1.63 M(-8.3%)
Mar 2014
-
$367.70 K(-38.7%)
$1.78 M(+3.1%)
Dec 2013
$1.72 M(+26.2%)
$599.70 K(+49.6%)
$1.72 M(+12.5%)
Sep 2013
-
$401.00 K(-1.4%)
$1.53 M(+9.6%)
Jun 2013
-
$406.90 K(+29.3%)
$1.40 M(+1.7%)
Mar 2013
-
$314.60 K(-23.0%)
$1.37 M(+0.6%)
Dec 2012
$1.36 M(+25.5%)
$408.50 K(+53.4%)
$1.36 M(+42.7%)
Sep 2012
-
$266.30 K(-30.6%)
$956.40 K(+37.9%)
Jun 2012
-
$383.70 K(+25.2%)
$693.40 K(+122.2%)
Mar 2012
-
$306.40 K(+9184.8%)
$312.00 K(+2300.0%)
Dec 2011
$1.09 M(+8264.6%)
-
-
Aug 2011
-
$3300.00(+43.5%)
$13.00 K(+19.3%)
Aug 2011
$13.00 K(+19.3%)
-
-
May 2011
-
$2300.00(0.0%)
$10.90 K(-7.6%)
Feb 2011
-
$2300.00(-54.9%)
$11.80 K(-7.1%)
Nov 2010
-
$5100.00(+325.0%)
$12.70 K(+16.5%)
Aug 2010
$10.90 K(-31.0%)
$1200.00(-62.5%)
$10.90 K(-31.4%)
May 2010
-
$3200.00(0.0%)
$15.90 K(+0.6%)
Feb 2010
-
$3200.00(-3.0%)
$15.80 K(-0.6%)
Nov 2009
-
$3300.00(-46.8%)
$15.90 K(+0.6%)
Aug 2009
$15.80 K(-27.5%)
$6200.00(+100.0%)
$15.80 K(-4.8%)
May 2009
-
$3100.00(-6.1%)
$16.60 K(-12.6%)
Feb 2009
-
$3300.00(+3.1%)
$19.00 K(-13.2%)
Nov 2008
-
$3200.00(-54.3%)
$21.90 K(+0.5%)
Aug 2008
$21.80 K(-2.2%)
$7000.00(+27.3%)
$21.80 K(+47.3%)
May 2008
-
$5500.00(-11.3%)
$14.80 K(+59.1%)
Feb 2008
-
$6200.00(+100.0%)
$9300.00(-12.3%)
Nov 2007
-
$3100.00(-58.7%)
$10.60 K(-59.2%)
Aug 2007
$22.30 K(-39.7%)
-
-
Feb 2007
-
$7500.00(+66.7%)
$26.00 K(+17.1%)
Nov 2006
-
$4500.00(-60.2%)
$22.20 K(-40.0%)
Aug 2006
$37.00 K(+182.4%)
$11.30 K(+318.5%)
$37.00 K(+28.0%)
May 2006
-
$2700.00(-27.0%)
$28.90 K(-4.9%)
Feb 2006
-
$3700.00(-80.8%)
$30.40 K(+13.9%)
Nov 2005
-
$19.30 K(+503.1%)
$26.70 K(+159.2%)
Aug 2005
$13.10 K(-45.9%)
$3200.00(-23.8%)
$10.30 K(+45.1%)
May 2005
-
$4200.00(+44.8%)
$7100.00(+144.8%)
Nov 2004
-
$2900.00
$2900.00
Aug 2004
$24.20 K
-
-

FAQ

  • What is VolitionRx Limited annual SGA?
  • What is the all time high annual SGA for VolitionRx Limited?
  • What is VolitionRx Limited annual SGA year-on-year change?
  • What is VolitionRx Limited quarterly SGA?
  • What is the all time high quarterly SGA for VolitionRx Limited?
  • What is VolitionRx Limited quarterly SGA year-on-year change?
  • What is VolitionRx Limited TTM SGA?
  • What is the all time high TTM SGA for VolitionRx Limited?
  • What is VolitionRx Limited TTM SGA year-on-year change?

What is VolitionRx Limited annual SGA?

The current annual SGA of VNRX is $16.92 M

What is the all time high annual SGA for VolitionRx Limited?

VolitionRx Limited all-time high annual SGA is $16.92 M

What is VolitionRx Limited annual SGA year-on-year change?

Over the past year, VNRX annual SGA has changed by +$514.70 K (+3.14%)

What is VolitionRx Limited quarterly SGA?

The current quarterly SGA of VNRX is $2.82 M

What is the all time high quarterly SGA for VolitionRx Limited?

VolitionRx Limited all-time high quarterly SGA is $5.36 M

What is VolitionRx Limited quarterly SGA year-on-year change?

Over the past year, VNRX quarterly SGA has changed by -$1.55 M (-35.53%)

What is VolitionRx Limited TTM SGA?

The current TTM SGA of VNRX is -$855.20 M

What is the all time high TTM SGA for VolitionRx Limited?

VolitionRx Limited all-time high TTM SGA is -$95.20 K

What is VolitionRx Limited TTM SGA year-on-year change?

Over the past year, VNRX TTM SGA has changed by -$872.12 M (-5154.53%)